Artificial blood

Medical Journal Armed Forces India

Volumn 59, Issue 1, 2003, Pages 45-50

  Goorha, Y K ^a   Deb, Prabal ^b   Chatterjee, T ^c   Dhot, P S ^d   Prasad, R S ^e  

^a Armed Forces Medical Store Depot   (India)

^b IMTRAT   (India)

^c BASE HOSPITAL   (India)

^d Armed Forces Transfusion Centre   (India)

^e Medical Services   (India)

Author keywords

Blood substitute; Haemoglobin solutions; Perfluorocarbons

Indexed keywords

ALBUMIN; ANTINEOPLASTIC AGENT; ARACHIDONIC ACID; ARTIFICIAL BLOOD; BENZENE; BLOOD SUBSTITUTE; CARBOXYLIC ACID; CARDIOPLEGIC AGENT; CONTRAST MEDIUM; CYTOKINE; DIASPIRIN CROSSLINKED HEMOGLOBIN; DRUG CARRIER; ENDOTOXIN; ERYTHROPOIETIN; FIBRINOGEN; FLUOSOL DA; GLUTARALDEHYDE; HEMOGLOBIN; LIGAND; OXYGEN; PERFLUORO COMPOUND; PERFLUORODECALIN; PERFLUOROOCTYL BROMIDE; PERFLUOROTRIPROPYLAMINE; PHOSPHATIDYLCHOLINE; POLOXAMER; POLYMERIZED HEMOGLOBIN; PROSTAGLANDIN; RECOMBINANT HEMOGLOBIN; UNINDEXED DRUG;

ANEMIA; ARTICLE; BACKACHE; BLOOD STORAGE; BLOOD TRANSFUSION; CHILL; CLINICAL TRIAL; COST BENEFIT ANALYSIS; DISEASE TRANSMISSION; DRUG APPROVAL; DRUG CONJUGATION; DRUG EFFICACY; DRUG HALF LIFE; DRUG HYPERSENSITIVITY; DRUG INDICATION; DRUG MECHANISM; DRUG SAFETY; DRUG SOLUBILITY; FEVER; FLU LIKE SYNDROME; FLUSHING; FOOD AND DRUG ADMINISTRATION; GASTROINTESTINAL SYMPTOM; HEADACHE; HEMORRHAGIC SHOCK; HEPATITIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEUKOCYTE ACTIVATION; LEUKOPENIA; OXYGEN TRANSPORT; SENSITIZATION; THORAX PAIN; THROMBOCYTOPENIA;

EID: 0344874748     PISSN: 03771237     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0377-1237(03)80107-7     Document Type: Review

References (28)

1. Tsuchida E. Introduction : Overview and perspectives. In : Tsuchida E, editor. Artificial red cells. Tokyo:John Wiley & Sons Ltd., 1995;1-20.
2. Scatena R, Giardina B. Raffinose-polymerised haemoglobin. A biochemical and pharmacological profile of an oxygen carrier. Expert Opin Biol Ther 2001;1(1):121-7.
3. Rabiner SF, Helbert JR, Lopas H, Bayne S. Evaluation of stroma-free haemoglobin solution for use as a plasma expander. J Exp Med 1967;129:1127-42.
4. Hoffman SJ, Looker DL, Roehrich JM, Halbert TR, Kondo A. Expression of fully functional tetrameric human haemoglobin in Escherichia coli. Proc Nat Acad Sci 1990;87:8521-5.
5. Swanson ME, Martin MJ, O'Donnell JK. Production of functional human haemoglobin in transgenic swine. Technol 1992;10:557-9.
6. Payne JW. Polymerisation of proteins with glutaraldehyde. Soluble molecular weight markers. Biochem J 1973;135:867-73.
7. Luhruma Z, Kabakeled M, Manzombi M, Kaluila M, Angelillo R, Feola M. Clinical trial of a haemoglobin-based blood substitute in patients with sickle cell crisis. Biomater Artif Cells Immobil Biotechnol 1991;19:328-34.
8. Chang TM. Red blood cell substitutes. Baillieres Best Pract Res Clin Haematol 2000;13(4):651-67.
9. Ajisaka K, Iwashita Y. Modification of human haemoglobin with polyethylene glycol: a new candidate for blood substitute. Biochem Biophys Res Commun 1980;97:1076-81.
10. Caron A, Malfatti E, Aguejouf O, Faivre-Fiorina B, Menu P. Vasoconstrictive response of rat mesenteric arterioles following infusion of cross-linked, polymerized, and conjugated haemoglobin solutions. Artif Cells Blood Substit Immobil Biotechnol 2001;29(1):19-30.
11. O'Hara JF, Colburn WA, Tetzlaff JE, Novick AC, Angermeier KW, Schubert A. Haemoglobin and methaemoglobin concentrations after large-dose infusions of diaspirin crosslinked haemoglobin. Anesth Analg 2001;92(1):44-8.
12. Abugo O O, Balagopalakrishna C, Rifkind JM, Rudolph AS, Hess JR, Macdonald VW. Direct measurements of haemoglobin interactions with liposomes using EPR spectroscopy. Artif Cells Blood Substit Immobil Biotechnol 2001;29(1):5-18.
13. Djordjevich L, Miller IF. Lipid encapsulated haemoglobin as a synthetic erythrocyte. Fed Proc 1977;21:567-71.
14. Alayash AI. Haemoglobin-based blood substitutes and the hazards of blood radicals. Free Radic Res 2000;33(4):341-8.
15. Spence RK. Blood substitutes. In : Petz Lawrence D, Swisher SN, Kleinman S, Spence RK, Strauss RG, editors. Clinical Practice of Transfusion Medicine, 3rd ed. New York:Churchill Livingstone, 1996:967-84.
16. Reiss JG, LeBlane M. Solubility and transport phenomena in perfluorochemicals relevant to blood substitution and other medical applications. Pure Appl Chem 1982;54:2383-8.
17. Waxman K, Tremper KK, Cullen BF, et al. Perfluorocarbon infusion in bleeding patients refusing blood transfusions. Arch Surg 1984;119:721-5.
18. Dinkelmann S, Rohlke W, Meinert H, Northoff H. A system establishment compatibility profiles for artificial oxygen carriers and other substances. Artif Cells Blood Substit Immobil Biotechnol 2001;29(1):57-70.
19. Reiss JG. The design and development of improved fluorocarbon-based products for use in medicine and biology. Artif Cells Blood Substit Immobil Biotechnol 1994;22:215-9.
20. Hong F, Shastri KA, Logue GL, Spaulding MB. Complement activation by artificial blood substitute Fluosol : in vitro and in vivo studies. Transfusion 1991;31:642-6.
21. Ivanitskii GR. Biophysics at the turn of the new millennium : perfluorocarbon media and gas transporting blood substitutes. Biofizika 2001;46(1):5-33.
22. Creteur J, Vincent JL. Haemoglobin solutions : an "all-in-one" therapeutic strategy in sepsis? Crit Care Med 2000;28(3):894-6.
23. Sekiguchi S, Kunihiko N. Near-term outlook for the blood service with blood substitutes in Japan. In:Tsuchida E, editor. Artificial Red Cells. Tokyo : John Wiley & Sons Ltd., 1995;259-75.
24. Chen HS, Yang ZH. Perfluorocarbons as blood substitute in clinical applications and war casualties, Biomat Artif Cells Artif Organs 1988;16:403-10.
25. Geyer RP. Potential uses of artificial blood substitutes. Fed Proc 1975;34:1525-8.
26. Paxian M. Synthetic oxygen carriers as an alternative to foreign blood transfusion. Anaesthesist 2001;50 Suppl 1:S43-9.
27. Vandegriff KD. Haemoglobin-based oxygen carriers. Expert Opin Investig Drugs 2000;9(9):1967-84.
28. Lee DH, Blajchman MA. Platelet substitutes and novel platelet products. Expert Opin Investig Drugs 2000;9(3):457-69.